-
1
-
-
33750057002
-
Biology and management of malignant pleural mesothelioma
-
DOI 10.1016/j.ejca.2006.07.011, PII S095980490600685X
-
Zucali PA, Giaccone G. Biology and management of malignant pleural mesothelioma. Eur J Cancer. 2006;42:2706-2714. (Pubitemid 44584672)
-
(2006)
European Journal of Cancer
, vol.42
, Issue.16
, pp. 2706-2714
-
-
Zucali, P.A.1
Giaccone, G.2
-
2
-
-
0036208368
-
Non-asbestos related diffuse malignant mesothelioma
-
Huncharek M. Non-asbestos related diffuse malignant mesothelioma. Tumori. 2002;88:1-9. (Pubitemid 34269790)
-
(2002)
Tumori
, vol.88
, Issue.1
, pp. 1-9
-
-
Huncharek, M.1
-
3
-
-
0030002040
-
Post-irradiation malignant mesothelioma
-
Cavazza A, Travis LB, Travis WD, et al. Post-irradiation malignant mesothelioma. Cancer. 1996;77:1379-1385.
-
(1996)
Cancer
, vol.77
, pp. 1379-1385
-
-
Cavazza, A.1
Travis, L.B.2
Travis, W.D.3
-
4
-
-
0019404059
-
Mesothelioma relative to asbestos, radiation, and methylcholanthrene
-
Warren S, Brown CE, Chute RN, Federman M. Mesothelioma relative to asbestos, radiation, and methylcholanthrene. Arch Pathol Lab Med. 1981;105:305-312. (Pubitemid 11047797)
-
(1981)
Archives of Pathology and Laboratory Medicine
, vol.105
, Issue.6
, pp. 305-312
-
-
Warren, S.1
Brown, C.E.2
Chute, R.N.3
Federman, M.4
-
5
-
-
25144512005
-
Second cancers among 40 576 testicular cancer patients: Focus on long-term survivors
-
Travis LB, Fossa SD, Schonfeld SJ, et al. Second cancers among 40 576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 2005;97:1354-1365.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1354-1365
-
-
Travis, L.B.1
Fossa, S.D.2
Schonfeld, S.J.3
-
6
-
-
34248227620
-
Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma
-
DOI 10.1200/JCO.2006.09.0936
-
Hodgson DC, Gilbert ES, Dores GM, et al. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol. 2007;25:1489-1497. (Pubitemid 46759253)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.12
, pp. 1489-1497
-
-
Hodgson, D.C.1
Gilbert, E.S.2
Dores, G.M.3
Schonfeld, S.J.4
Lynch, C.F.5
Storm, H.6
Hall, P.7
Langmark, F.8
Pukkala, E.9
Andersson, M.10
Kaijser, M.11
Joensuu, H.12
Fossa, S.D.13
Travis, L.B.14
-
7
-
-
33947514106
-
Therapeutic radiation for lymphoma: Risk of malignant mesothelioma
-
DOI 10.1002/cncr.22526
-
Teta MJ, Lau E, Sceurman BK, Wagner ME. Therapeutic radiation for lymphoma: risk of malignant mesothelioma. Cancer. 2007;109:1432-1438. (Pubitemid 46466572)
-
(2007)
Cancer
, vol.109
, Issue.7
, pp. 1432-1438
-
-
Teta, M.J.1
Lau, E.2
Sceurman, B.K.3
Wagner, M.E.4
-
8
-
-
33745311546
-
The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma
-
DOI 10.1002/cncr.21971
-
Tward JD, Wendland MM, Shrieve DC, Szabo A, Gaffney DK. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma. Cancer. 2006;107:108-115. (Pubitemid 43939037)
-
(2006)
Cancer
, vol.107
, Issue.1
, pp. 108-115
-
-
Tward, J.D.1
Wendland, M.M.M.2
Shrieve, D.C.3
Szabo, A.4
Gaffney, D.K.5
-
9
-
-
0142121297
-
Long-term cause-specific mortality of patients treated for Hodgkin's disease
-
DOI 10.1200/JCO.2003.07.131
-
Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol. 2003;21:3431-3439. (Pubitemid 46603515)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.18
, pp. 3431-3439
-
-
Aleman, B.M.P.1
Van Den Belt-Dusebout, A.W.2
Klokman, W.J.3
Van'T Veer, M.B.4
Bartelink, H.5
Van Leeuwen, F.E.6
-
10
-
-
0028154066
-
Second cancer risk following Hodgkin's disease: A 20-year follow-up study
-
van Leeuwen FE, Klokman WJ, Hagenbeek A, et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol. 1994;12:312-325. (Pubitemid 24056405)
-
(1994)
Journal of Clinical Oncology
, vol.12
, Issue.2
, pp. 312-325
-
-
Van Leeuwen, F.E.1
Klokman, W.J.2
Hagenbeek, A.3
Noyon, R.4
Van Den Belt-Dusebout, A.W.5
Van Kerkhoff, E.H.M.6
Van Heerde, P.7
Somers, R.8
-
11
-
-
0033952110
-
Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood
-
van Leeuwen FE, Klokman WJ, Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol. 2000;18:487-497. (Pubitemid 30078530)
-
(2000)
Journal of Clinical Oncology
, vol.18
, Issue.3
, pp. 487-497
-
-
Van Leeuwen, F.E.1
Klokman, W.J.2
Van'T Veer, M.B.3
Hagenbeek, A.4
Krol, A.D.G.5
Vetter, U.A.O.6
Schaapveld, M.7
Van Heerde, P.8
Burgers, J.M.V.9
Somers, R.10
Aleman, B.M.P.11
-
12
-
-
33847348995
-
Late cardiotoxicity after treatment for Hodgkin lymphoma
-
DOI 10.1182/blood-2006-07-034405
-
Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood. 2007;109:1878-1886. (Pubitemid 46348183)
-
(2007)
Blood
, vol.109
, Issue.5
, pp. 1878-1886
-
-
Aleman, B.M.P.1
Van Den Belt-Dusebout, A.W.2
De Bruin, M.L.3
Van 'T Veer, M.B.4
Baaijens, M.H.A.5
De Boer, J.P.6
Hart, A.A.M.7
Klokman, W.J.8
Kuenen, M.A.9
Ouwens, G.M.10
Bartelink, H.11
Van Leeuwen, F.E.12
-
13
-
-
0004299806
-
-
World Health Organization 3rd Ed. Geneva, Switzerland: World Health Organization
-
World Health Organization. International Classification of Diseases for Oncology, 3rd Ed. Geneva, Switzerland: World Health Organization; 2000.
-
(2000)
International Classification of Diseases for Oncology
-
-
-
14
-
-
0032863510
-
Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of the Netherlands since 1970: A population-based study
-
Janssen-Heijnen ML, Damhuis RA, Klinkhamer PJ, Schipper RM, Coebergh JW. Increased but low incidence and poor survival of malignant mesothelioma in the southeastern part of The Netherlands since 1970: a population-based study. Eur J Cancer Prev. 1999;8:311-314.
-
(1999)
Eur J Cancer Prev
, vol.8
, pp. 311-314
-
-
Janssen-Heijnen, M.L.1
Damhuis, R.A.2
Klinkhamer, P.J.3
Schipper, R.M.4
Coebergh, J.W.5
-
16
-
-
0037028736
-
Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease
-
Travis LB, Gospodarowicz M, Curtis RE, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J. Natl Cancer Inst. 2002;94:182-192. (Pubitemid 34162752)
-
(2002)
Journal of the National Cancer Institute
, vol.94
, Issue.3
, pp. 182-192
-
-
Travis, L.B.1
Gospodarowicz, M.2
Curtis, R.E.3
Clarke, E.A.4
Andersson, M.5
Glimelius, B.6
Joensuu, T.7
Lynch, C.F.8
Van Leeuwen, F.E.9
Holowaty, E.10
Storm, H.11
Glimelius, I.12
Pukkala, E.13
Stovall, M.14
Fraumeni Jr., J.F.15
Boice Jr., J.D.16
Gilbert, E.17
-
17
-
-
0028881826
-
Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease
-
van Leeuwen FE, Klokman WJ, Stovall M, et al. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst. 1995;87:1530-1537.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 1530-1537
-
-
Van Leeuwen, F.E.1
Klokman, W.J.2
Stovall, M.3
-
18
-
-
0021224497
-
Non-asbestos-related malignant mesothelioma: A review
-
Peterson JT Jr, Greenberg SD, Buffler PA. Non-asbestos-related malignant mesothelioma: a review. Cancer. 1984;54:951-960.
-
(1984)
Cancer
, vol.54
, pp. 951-960
-
-
Peterson Jr., J.T.1
Greenberg, S.D.2
Buffler, P.A.3
-
19
-
-
24944522720
-
A mouse model recapitulating molecular features of human mesothelioma
-
Altomare DA, Vaslet CA, Skele KL, et al. A mouse model recapitulating molecular features of human mesothelioma. Cancer Res. 2005;65:8090-8095.
-
(2005)
Cancer Res
, vol.65
, pp. 8090-8095
-
-
Altomare, D.A.1
Vaslet, C.A.2
Skele, K.L.3
-
20
-
-
0022398886
-
Correlation of in vitro genotoxicity and oncogenicity induced by radiation and asbestos fibres
-
Hei TK, Geard CR, Osmak RS, Travisano M. Correlation of in vitro genotoxicity and oncogenicity induced by radiation and asbestos fibres. Br J Cancer. 1985;52:591-597. (Pubitemid 16221581)
-
(1985)
British Journal of Cancer
, vol.52
, Issue.4
, pp. 591-597
-
-
Hei, T.K.1
Geard, C.R.2
Osmak, R.S.3
Travisano, M.4
|